C-Path Institute is a nonprofit organization that works on improving medical product development and regulation. According to filings, it lobbied Congress and the federal government for funding for the Food and Drug Administration’s Critical Path programs and on FDA-related health issues, including the Act for ALS legislation. Its filings show small-scale spending and it used American Capitol Group to represent it.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DAVE LARSON
The latest disclosures for this client.
AMERICAN CAPITOL GROUP
Q3AMERICAN CAPITOL GROUP
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
AMERICAN CAPITOL GROUP
AMERICAN CAPITOL GROUP
Q1AMERICAN CAPITOL GROUP
Q4AMERICAN CAPITOL GROUP
Q3AMERICAN CAPITOL GROUP
Q2AMERICAN CAPITOL GROUP
Q1